Calumet (CLMT) Q2 2026 earnings — TrendMatrix coverage
Reported
Model-generated analysis — not investment advice. Not a registered investment advisor. Past performance does not guarantee future results. How we score · Full disclosure
Key numbers
- Adjusted EPS
- $0.68
- Estimate
- $0.16
- Surprise
- +323.7%
- Revenue (period 2026-06-30)
- $1.45B
- Score today
- 5.7/10
Revenue source: xbrl.
How the report landed
Calumet (CLMT) beat the $0.16 estimate with adjusted EPS of $0.68 — a large 323.7% upside surprise.
Where TrendMatrix's rating stands now
TrendMatrix currently rates CLMT Sell at 5.7/10; no pre/post engine snapshot brackets this report.
4 of the last 4 quarters beat the estimate; this quarter's +323.7% surprise compares with a +141.6% four-quarter average. Next scheduled report: 2026-11-06.
What argues against it
- Target reached (-17.3% upside)
- Quality below floor (1.9 < 4.0)
- Negative risk/reward — downside exceeds upside
This section and the ones below it reflect TrendMatrix’s latest engine read — they update after the report date and are not frozen to it.
The levels TrendMatrix's engine tracks
- Current price
- $56.21
- Price target
- $58.67
- Stop
- $52.28
- Upside to target
- +4.4%
Model outputs from TrendMatrix’s engine as of 2026-10-07 — shown for context, not personalized investment advice.
CLMT at TrendMatrix's latest read
Materials producers report against the commodity cycle — realized-price capture and volume, not the EPS line, are the tells in a quarter like this.
- Industry
- Specialty Chemicals
- Market cap
- $4.92B
- P/E (fwd)
- 88.9
- 52-week range
- $17.42–$59.87
- Off 52-week high
- 6.1%
- RSI (14)
- 43
- Volume vs avg
- 0.54×
- Score today
- 5.7/10